LUNAR: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (Ttfields) Concurrent with Standard of Care Therapies for Treatment of Stage 4 Non-Small Cell Lung Cancer (NSCLC) Following Platinum Failure
March 23, 2021 / 0 Comment(s)
ACT16482: Phase 1-2 Trial Evaluating Anti-TGFB; Agent (SAR439459) or Pomalidomide in Combination with Isatuximab and Dexamethasone in Relapsed or Refractory Multiple Myeloma (RRMM)
March 23, 2021 / 0 Comment(s)
CBYL719H12301: A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer With Either Phosphoinositide-3-kinase Catalytic Subunit Alpha (PIK3CA) Mutation or Phosphatase and Tensin Homolog Protein (PTEN) Loss Without PIK3CA Mutation
March 16, 2021 / 0 Comment(s)